pharma · Urea cycle disorders (UCD) · Cannabis Smoking · CAMP
Camp4 Therapeutics
Camp4 Therapeutics Corp
Camp4 Therapeutics is a pharma organization headquartered in Cambridge, USA. It trades on NYSE under ticker CAMP. Primary therapeutic focus areas include Urea cycle disorders (UCD), Cannabis Smoking, Subjective Tinnitus,
Cambridge, USA HQ
2016 Founded
60 Employees
Public company Type
CAMP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2016
- Employees
- 60
- Programs
- 9
- Drugs
- 15
- Patents
- 4
Placebo
Phase 3 · small molecule · Asthma
Placebo for Asthma is a Phase 3 program (small_molecule) at Camp4 Therapeutics Corp with 1 ClinicalTrials.gov record(s).
Internal code 213
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Camp4 Therapeutics Corp
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Asthma
- Status
- completed
- Trials
- 1